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WITH MY LOVE 
NORMAL ADULT RAT LIVER 
IMMEDIATELY AFTER PARTIAL HEPATECTOMY 
Caudate lobe; anterior and posterior segments of right lateral 
lobe. Note last named crossing the upper pole of the right 
kidney. 
8 HOURS AFTER PARTIAL HEPATECTOMY 
Note fatty infiltration 
10 DAYS AFTER PARTIAL HEPATECTOMY 
Note hypertrophy of the lobes; the posterior segment of the 
right lateral lobe now extending well below the lower pole 
of the right kidney. 
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REVIEW OF LIVER CELL PROLIFERATION 
REVIEW OF LIVER CELL PROLIFERATION 
The latent capacity of the liver for growth, 
which is unmatched by any other mammalian organ, has 
long been and still is a source of fascination. In 
spite of the fact that mature liver c ells are long lived -
in rats and mice they may even survive for the adult 
life of the animal - the simple expedient of partial 
he pa tectom y s ets into motion a burst of astonishingly 
rapid proliferation. In the normal rat and mouse, one 
mitosis is seen in about 10,000 to 20,000 hepatocytes, 
just sufficient to allow for nor ma l bod y growth. 
Following partial hepatectomy, however, the rate of cell 
division is nearly once in every 24 hours, a rate which 
is as rapid as that seen· in ma n y embr yonic and cultured 
c ells and exceeds that in most neop l astic cell s (B rues 
et al, 1936; Fabrikant, 1967). In addition to this, the 
growth is finely controlled, tapering off and ceasing 
when restoration of the original cell mass is complete. 
The proliferative capacity of the liver is 
well illustrated in the rat by the almost complete 
restoration of its mass after repe a ted resection, even 
when a partial hepatectomy is performed every month for 
a year (Ingle and Baker, 1957; Simpson and Finckh, 1963). 
Liver mass is restored with extraordinary rapidity, the 
residual lobes in normal adult animals nearly doubling 
in size in 48 hours and approaching the original liver 
weight in seven days ( Brues et al, 1936; Bucher and Malt, 1971a). 
1 . 
Some discussion has ensued regarding the term 
'regeneration' as it is used in the context 'liver regener-
ation'. Fishback wrote in 1929: "The real meaning of 
'regeneration' is restoration of tissue or part of an 
organ at the site of its removal, and the term implies 
compensation, either structural, as of a part, or 
physiologic, as of a function. In the restoration of 
hepatic tissue after partial hepatectomy, the replacement 
does not occur at the stump from which the lobes are 
removed, but within the remaining lobes, so that 
'restoration' or 'restitution' might describe the process 
more accurately". 
Fishback was supported by Higgins and Anderson 
(1931): "In the case of the mammalian liver one is dealing 
with a response in growth considerably different from that 
which ensues on the removal of the tadpole's tail. 
Following partial removal of the liver, proliferation of 
cells does not ensue at the level of the cut; new lobes 
do not develop to take the place of those removed. There 
is, on the other hand, hyperplasia of the remaining lobes. 
There are no centres of cell proliferation, but generalized 
mitotic activity, coupled with cellular migration and 
differentiation, results in the formation of new lobes, 
and the pre-operative weight of the liver is thus rapidly 
restored. Regeneration as employed biologically would 
involve, it seems to us, the replacement of a removed 
part, with rearrangement or reorganization of the old part. 
This term could well be applied to the recovery of the 
hepatic lobule from chemical injury as, for example, 
2. 
chloroform or carbon tetrachloride poisoning, in which 
there is not only reorganization of portions of the old 
lobule, but new cellular proliferation as well". 
Bucher and Malt (1971b) added further support: 
"Regeneration of the _liver is more properly described as 
a compensatory hyperplasia which involves growth of 
residual lobes rather than regrowth of those that were 
excised". The s e authors a ppe a r to be supported by the 
Shorter Oxford English Dictionary which defines the verb 
'regenerate' thus: " ....•... ( 2 ) Path. 
form afresh ( some p a rt of the body ) ". 
To reproduce, 
The author h as 
accordingly, in keeping with current terminology, used 
the term 'liver cell proliferation', which accurately 
describes the phenomenon. 
It is the early period of cellular growth and 
division that is the time of greatest interest, when 
metabolic activity centres around synthesis of new 
hepatic cells, before moving toward compensation of 
impaired liver function. In the rat the period of maximal 
liver cell prolifer a tion is at about 22 hours after 
hepatectomy ( Grisham 1962). In man it is estimated, 
by means of scintillation scanning studies using various 
radioactive substances, that the hepatic mass is fully 
restored in about six months (McDermott et al, 1963). 
At the microscopic level, changes occur first in 
the parenchymal cells, which constitute 90-95% of the 
total hepatic cellular volume, but only 6 0-65% of the 
cell population, there being infiltration with lipid 
and loss of glycogen within a few hours. The cells, 
3. 
nuclei and nucleoli enlarge, smooth endoplasmic reticulum 
increases, lysosomes may become more prominent, and some 
autophagocytosis is observed. Deoxyribonucleic acid (DNA) 
synthesis is first observed 16 - 18 hours after partial 
hepatectomy and occurs first in cells at the periphery of 
the lobule, later spreading toward the centre, reaching 
peak activity at 20 - 24 hours, then declining. Mitosis 
follows the same pattern 6 - 8 hours later. In proliferation, 
compared to developmental growth, the cell cycle is 
shortened, especially in the G1 phase, 
after an initial lag 
(Bucher and Malt, 1971c), (Fig. 1). After partial hepa-
tectomy (or treatment with growth hormone) polyamine 
synthesis is stimulated; the increase in ornithine 
decarboxylase (which mediates the first step in biogenesis 
of the polyamines spermine and spermidine) activity being 
manyfold within as short a space of time as 15 minutes 
(personal observation). The half-life of ornithine decar-
boxylase is 11 minutes in both normal and partially hepa-
tectomized livers and is the shortest on record for any 
enzyme, its nearest rival being 6 - 7 times longer 
(Russel and Snyder, 1969). 
The idea that the remaining mass of the liver is 
quickly restored after loss of a portion comes down from 
antiquity. Fishback (1929) suggested that the phenomenon 
was first revealed in the myth concerning Prometheus, he 
having to pay cruelly for his trickery and thefts. At 
the command of Zeus, Prometheus was bound with indestruct-
ible chains to one of the crests of Mount Caucasus. There 
4. 




S, period of DNA synthesis; D or M, period of 
mitosis & division; G 1 & G 2 , intervals (gaps) 
between these sharply defined nuclear events 
"an eagle with outstretched wings, sent by Zeus, fed 
upon his immortal liver; as much as the winged monster 
devoured, during the day, that much grew again during the 
night". 
An indication of the degree of interest which 
has long been shown in this subject is given by Fishback 
when, as long ago as 1929, he described the literature on 
liver cell proliferation as "exceedingly comprehensive". 
However, the mechanism by which this liver cell prolifer-
ation is initiated and controlled remains tantalizingly 
obscure, although two distinct sources of the stimulus 
have been invoked; namely, a specific humoral agent, the 
concentration of which changes following partial hepatectomy 
and secondly, the haemodynamic or metabolic load imposed 
on the remnant as a result of resection. 
While the intensive search for the clue to the 
control of liver cell proliferation is in part academic, 
its discovery has important clinical considerations: 
during the period 1963-1971, a total of 492 patients 
with the presumed diagnosis of acute hepatitis were 
treated by the Liver Research Group of the University of 
Cape Town. Of these, 119 patients (24.2%) had evidence 
of hepatic encephalopathy. Using a classification of 
hepatic coma adapted from Adams and Foley (1949), 51 
patients were found to be in grade II or III coma 
while 68 patients with massive hepatic necrosis had 
grade IV coma. The survival rate of patients in deep 
hepatic coma without special treatment is under 10% 
(Trey and Davidson, 1970). While viral hepatitis accounted 
5 • 
for the majority of cases, the Cape Town series included a 
few patients with halothane hepatitis and drug induced 
hepatitis. 
It nas been suggested that the key to recovery 
from massive hepatic necrosis lies in liver cell prolifer-
ation ( Saunders et al, 1972; Bucher 1978). Further, 
studies of this phenomenon of liver cell proliferation 
are relevant to neoplasia, especially with regard to the 
concept that in the adult stage the factors controlling 
cell proliferation may be switched 'on' and 'off' but in 
cancer they appear to be permanently 'on' ( Potter, 1969). 
6. 
I N T R O D U C T I O N 
INTRODUCTION 
While restoration of hepatic tissue by cellular 
growth and division is of clinical interest so, too, are the 
consequences of the inevitable impariment of hepatic function 
which must accompany reduction in hepatic mass - be this 
due to infection, destruction by toxins or partial surgical 
excision for trauma or neoplasia. Since partial hepatectomy 
brings about that rapid liver cell proliferation which is 
peculiar to the liver, any studies following partial 
hepatectomy are inextricably concerned with the phenomenon 
of liver cell proliferation. 
One of the striking problems following partial 
hepatectomy in man is a fall in the plasma albumin which 
occurs in the immediate post operative period. Recent 
work reviewed here indicates that albumin metabolism may 
be influenced in vitro and in vivo by "hyperalimentation" 
with amino acids and other manoeuvres. It was accordingly 
decided to study albumin metabolism after partial hepatectomy 
and to evaluate the effects of supplementary amino acids 
and hydrocortisone on albumin sysnthesis in this situation. 
Albumin metabolism has been extensively studied 
and reviewed (Tavill, 1972; Rothschild, 1973; Schreiber 
1978) and it is not the author's intention that it oe 
further reviewed here. 
A great deal of information regarding albumin 
synthesis is available - it is produced in the liver and 
within the hepatocyte there exists a complex mechanism 
geared for the ~ynthesis of export proteins. 
7. 
This system consists of a strand of messenger ribonucleic 
acid to which is attached two ribosomal subunits (Blobel 
and Potter, 1967; 
Staehelin, 1970; 
Sabatini et al, 1966; 
Weignand et al, 1971). 
Falvey and 
The larger 
of these subunits is attached to the microtubular structure, 
the Bndoplasmic reticulum. As the albumin molecule is 
synthesized, it is inserted through the centre of the 
larger ribosomal sub-unit into the cisternal space of 
the endoplasmic reticulum and then, traversing both 
the smooth reticulum and the Golgi apparatus, is extruded 
in some fashion directly into hepatic plasma (Peters et al, 
1971 ). In vivo, newly synthesized albumin is deposited 
directly into hepatic plasma and hepatic lymph plays an 
insignificant role in the delivery of albumin to the 
systemic circulation (Woolley and Courtice, 1962; 
Smallwood et al, 1968). 
While it is well known that the plasma albumin 
level falls following partial hepatectomy (Chanutin et al, 
1938; Islami et al, 1956; Pack and Molander, 1960; 
McDermott et al, 1963; Monaco et al, 1964; McDermott 
and Ottinger, 1966; Almersjo and Bengmark, 1969; 
Aronsen et al, 1969; Dillard, 1969; Flatmark et al, 
1973) and after major surgery (Hoye et al, 1972) the 
relative contribution of alterations in dietary intake, 
album1n synthesis rate or albumin catabolic rate have 
not been delineated. There is little literature 
available concerning albumin synthesis rates following 
partial hepatectomy and that which is available is 
conflicting (vide infra). 
8 • 
As early as 1938, Chanutin et al reported a fall 
in plasma albumin following partial hepatectomy in rats. 
In 1951, Miller et al published a paper establishing the 
liver as the sole source of albumin synthesis: a fall 
in plasma albumin is hence the anticipated consequence of 
partial hepatectomy, which removes a good portion (2/3rds) 
of the albumin synthetic machinery. Using liver slices, 
Guidotti et al (1959) showed no significant change, in 
terms of liver weight, in albumin synthesis rates following 
partial hepatectomy, although observing an increase in 
'albumin turnover'. He suggested the fall in plasma 
album1n was due to increased utilization of plasma 
albumin in hepatic tissue restoration. This was confirmed 
(in terms of liver weight) by Braun et al (1962) using 
incorporation of 
14 C-amino acids into albumin in vivo 
and in vitro (tissue slices), by Rosenoer et al (1970) 
using the isolated perfused rat liver and by Schreiber 
et al (1971) using the 
14 C-leucine technique in vivo. 
In 1966, however, Mutschler and Gordon, using 
. 1 t d t 1· f . d th 14 Cl · iso a e ra iver per usions an e - eucine 
incorporation technique, showed a diminished synthesis 
of albumin during regeneration. These results were later 
confirmed, in terms of liver weight, by Murray-Lyon and 
Muller-Eberhard (1973) in vivo studies. 
Yet more conflicting results were produced by 
Majumdar et al (1967), using the 
14 C-leucine incorporation 
technique in tissue slices, who demonstrated that partial 
hepatectomy and acute distress (produced by intra-peritoneal 
injection of Celite) caused an increase in the albumin 
synthesis rate, in terms of liver weight. 
9. 
As discussed later in principles of methodology, 
the techniques used by some of the above workers for 
measuring albumin synthesis are open to criticism. 
The factors regulating degradation of plasma albumin 
are not well understood: moreover, degradative mechanisms 
and sites are unknown. While the factors controlling 
albumin catabolism are not altogether clear, it has been 
shown to be influenced by a number of factors. Plasmapho-
resis (Hoffenberg et al, 1966), protein calorie malnutrition 
(Kirsch et al, 1968a and Kelman et al, 1972a)and protein 
~ 
deprivation (Hoffenberg et al, 1970) have all been shown 
to cause a reduction in the albumin catabolic rate. It is 
interesting to note that in protein calorie malnutrition 
the fall in the albumin catabolic rate follows a fall in the 
plasma albumin pool which in turn is secondary to a reduced 
albumin synthesis rate. 
Albumin is not a suicidal protein and the 
degradative mechanism handles old and new molecules alike. 
Thus, wherever the degradative system is located, the cell 
membrane must find an affinity for this albumin molecule 
regardless of its life span. It is conceivable that this 
liver produced protein is somehow considered foreign by 
this degradative mechanism and that the degrading system 
is saturated with albumin molecules at all times. (Rothschild, 
1973). 
Many tissues have been implicated and studied as 
potential sites for this degradative mechanism. The kidney 
has been shown not to play a significant role in albumin 
degradation in the absence of renal disease, but may play 
an active role in disease (~ensen et al, 1967i Marsh and 
1 0 • 
Drabkin, 1958; Bourdeau et al, 1972; Mogielnicki et al, 
1971). In vitro studies indicate that the liver does 
not account for more than 10 - 14% of the total albumin 
catabolic rate (Cohen and Gordon, 1958). The intestinal 
tract is another organ which has been found to play a 
significant role in albumin degradation in disease but not 
to be of importance in the normal state (Jeejeebhoy 
et al, 1969; Kerr et al, 1967). Loss through the normal 
intestinal tract again probably accounts for less than one 
tenth of the total albumin degradation. 
While albumin catabolism following major surgery 
( Hoye et al, 1972) burns (Birke et al, 1959/60) and protein 
calorie deprivation ( Kelman et al, 1972a; Kirsch et al, 
1968a; Hoffenberg et al, 1970) has been extensively 
investigated, studies of the degradation of albumin 
following hepatic resection are limited and the results 
are conflicting (Almersjo and Bengmark, 1969; Scornik, 
1972). The former workers, using 
131 I and 125
 1 labelled 
albumin, in humans subjected to 20 - 80% hepatic resections 
observed a rise in albumin catabolism no different to that 
occurring after major surgery. Scornik, on the other hand, 
using mice and L-arginine (guanido -
14 c) found a dramatic 
reduction in the rate of protein degradation following 
partial hepatectomy. 
Of the many factors influencing albumin synthesis, 
the most important appears to be nutrition and more specifi-
cally the supply of amino acids. Withholding food from 
animals causes a reduction in albumin synthesis of the 
order of 50 per cent which occurs within 24 hours 
1 1 • 
(Kirsch et al, 1968; 
al, 1978). 
Rothschild et al, 1969: Pain et 
Using the isolated perfused rat liver the role of 
amino acids in the regulation of albumin synthesis has been 
studied extensively. Individual amino acids, as well as 
mixtures of amino acids, have been shown to enhance 
albumin synthesis in malnutrition (K irsch et al, 1969: 
Rothschild et al, 1969; Kelman et al, 1972b; Lundholm et 
al, 1977) and after exposure of the liver to alcohol 
(Rothschild et al, 1971; Kirsch et al, 1973; Jeejeeb-
hoy et al, 1972). 
The effect of cortisone on albumin synthesis and 
catabolism has been investigated ( Grossman et al, 1960; 
Schauder and Buck, 1971) and has been shown to increase 
albumin synthesis per se (Bancroft et al, 1969). 
It will be observed that some of the literature 
quoted in this introduction is ten years old and that 
the laboratory work on which this thesis is based was 
carried out in 1972 and 1973. Due to an unexpected 
increase in clinical responsibilities the author has 
been unable to publish this thesis earlier but every 
effort has been made to update the literature and it 
transpires that while the results published in this 
thesis have stimulated further research (see Discussion) 
the work has not been duplicated as far as can be estab-
lished by a thorough examination of the English language 
literature. 
1 2 • 
The author could find no studies in the English 
literature concerning the effects of amino acids or cortisone 
( or related compounds) on the albumin synthesis rate 
following partial hepatectomy. In the work reported here 
the a uthor set out to investigate five aspects of albumin 
metabolism following partial hepatectomy in the rat. 
1. The plasma albumin levels following partial 
hep a te c tom y . 
2. The effect of partial hepatectomy on the 
albumin synthesis rate. 
3. The effect of supplement a ry a mino a cids on 
the albumin synthesis rate f ollowing partial 
hepatectomy. 
4. The effect of hydrocortisone on the albumin 
synthesis rate following partial hep a te c tomy. 
5. The effect of partial hepatectomy on the 
albumin catabolic rate. 
1 3 • 
P R I N C I P L E S 0 F M E T H O D O L O G Y 
PRINCIPLES OF METHODOLOGY 
1 . Albumin Synthesis 
The use of radioactive isotopes in research is 
now taken for granted. Prior to their advent nitrogen 
balance studies were carried out, when albumin synthesis was 
derived from catabolic studies o f s ubject s in nutritional 
equilibrium when synthesis was presumed to equal cata-
bolism. This had many disadvantages, not least of which was 
its dependence on steady state conditions. 
The method by which radioa c tive isotopes are 
employed for measurement of albumin synthesis rates is 
based on the precursor-product principle. Labelled 
am i no acids are used and synthesis determined from the 
ratio of protein-bound radioactivity relative to the 
labelled amino acid at the site of protein synthesis. 
The main source of inaccuracy of this method is the 
difficulty of deriving precursor amino acid radioactivity 
at the site of protein synthesis since this is dependent 
on so many variables, viz: rate of incorporation of 
labelled amino acids into the protein, which in turn 1s 
dependent on the ratio of labelled amino acids to the 
total concentration of that amino acid; this depends again 
on the dose of labelled amino acids administered, blood 
flow to the organ, transport across cell membrane, 
intracellular compartmentation, synthesis and degradation 
of amino acids, catabolism of protein and supply of 
unlabelled amino acids (Fig. 2). 
























Figure2. FACTORS INFLUENCING THE PRECURSOR 
AMINO ACID SPECIFIC ACTIVITY 
The need for an accurate extra-cellular 
indicator of intra-cellular precursor activity stimulated 
the work of Delluva and Wilson (1946), who demonstrated 
that 14 carbonate combines with endogenously produced 
ammonia and ornithine in the liver to form arginine 
labelled only in the guanidine carbon atom. Some of the 
arginine is then used in the synthesis of hepatic proteins 
including albumin while the guanidine carbon of other 
arginine molecules is removed by arginase resulting in the 
production of (
14 c) urea. (Fig. 3). Swick (1958) suggested 
that urea released from the liver could be used as an 
indicator of the specific activity of the guanidine 
carbon of intra-cellular arginine. This work led to 
the development of the technique known as the (
14
c) 
carbonate technique for liver-produced plasma protein 
synthesis, the principles of which were defined independently 
by Reeve et al (1963) and McFarlane (1963a). 
The method has been mathematically defined by Reeve 
et al (1963) and Reeve (1963) and in a series of papers 
a number of workers (McFarlane 1963a & b; McFarlane et al, 
1965; Regoeczi et al, 1965; Rosenoer, 1967) have discussed 
the theoretical basis for the techniques and the various 
assumptions that need to be made in applying it, and have 
justified the method by comparing albumin synthesis rate 
d · d f 
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The formula used by Mcfarlane (1963a) and by Reeve 
et al (1963) was derived as follows: The radio-activity 
appearing in a protein, and in any other direct product of 
6 - 14 c - arginine, in a given time, is a function of the 
integral of the precursor arginine specific activity curve 
over the interval in question. Therefore, the radioactivity 
of the guanidine-carbon appearing in protein and urea in a 
gi ven time will bear the same ratio as the respective masses 
of guanidine-carbon synthesized. That is to say: in two 
products arising from the same precursor the ratio of the 
activities of the products is equal to the ratio of the rates 
of incorporation of the precursor into the products: 
Synthesis rate of albumin 
guanidine carbon 
Total activity in albumin 
guanidine carbon at timet 
= 
Synthesis rate of urea carbon Total activity in urea 
carbon at timet 
Equation 1. 
figure 4. 
The system is presented in simplified form in 
The common precursor pool consists of units each 
emitting 10 counts per minute. For each molecule of arginine 
in albumin or of urea synthesized, one unit of precursor is 
depicted as being utilized. 
Thus: 
Mass of albumin radioactivity of albumin i.e. 50 
= = 
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Precursor pool (in cpm) 
10 10 10 10 10 
10 10 10 10 10 
10 10 10 10 10 
10 10 10 10 10 
10 10 10 10 
2 molecules of urea 
10 10 
10 
5 molecules of arginine in albumin 
Figure 4. Principle of the carbonate method. 
If the total radioactivity incorporated into albumin 
and urea and absolute rate of urea synthesis are known, the 
absolute rate of albumin synthesis can be calculated. 
In vivo study 
A model of the system is shown in Figure 5. For 
prectical purposes urea is synthesized exclusively in the liver 
( Bollman et al, 1924; Kornberg et al, 19 52: Ta vill et al, 
1968). The mass of urea produced cannot be measured simply 
from the product of the fractional synthesis rate of urea 
and the urea pool as inaccuracies exist in the measurement 
of the size of the urea body pool ( Regoeczi et al, 1965). 
In addition, the assumption that the urea is present through-
out the body water at the same concentration as in the plasma 
may be invalid. After McFarlane et a l ( 19 6 5 ) equation 1 is 
modified by dividing both sides by the sizes of the urea 
carbon and guanidine carbon pools: 
FSR albumin SA * albumin at timet 
= 
FSR urea SA urea at timet 
..... Equation 3. 
(where FSR = fractional synthesis rate). 
OR: 
FSR albumin = 
FSR urea x SA* albumin timet 
SA urea at timet 
..... Equation 4. 
* S.A. = Specific activity 





















Figure 5. The arginine,albumin & urea pools of the carbonate 
method in vivo. 
At t albumin SA 
0 
= Specific Activity of the guanidine carbon 
of arginine in albumin at zero time. 
The absolute synthesis rate of albumin (mg/24 hrs.) formula: 
Albumin synthesis rate= FSR albumin x intravascular albumin pool 
Equation 5. 
In vivo, due to the losses of urea that occur during 
measurement (see Fig. 5), a hypothetical maximum value for 
( 14 c) urea specific activity has to be obtained. This is 
done by extrapolating the curve of plasma urea specific 
activity to zero time. Similarly the hypothetical specific 
radioactivity of albumin was obtained by extrapolation to 
zero time, correcting the 6 hour value by a factor derived from 
the distribution and catabolism of the (
125
1) albumin injected 
14 
at the same time at C Carbonate. 
In vitro (perfusion) st~ 
The system is assumed closed and is depicted in 
Figure 6. Equation 1 can be modified. 
Mass of albumin synthesized in time t 
Radioactivity incorporated into 
guanidine carbon of arginine 
in albumin int 
X 
= 
Mass of urea synthesised 
int 
Radioactivity incorporated into urea int. 
Equation 6. 
Previous workers in this laboratory have used this method 



















UREA POOL ! 
UREA 
DEGRADATION 
Figure 6. The arginine, albumin & urea pools of the carbonate 
method in the perfusion system (in vitro ) 
Kirsch (1968) have carried out further experiments validating 
the in vivo technique by comparing albumin synthesis rates 
derived from the (
14
c) carbonate technique with those from 
1 3 1 
albumin catabolic rates obtained using Iodine-albumin in 
steady state animals. 
2 . Albumin Catabolism 
Iodine labelled albumin was introduced in the 1950's 
in the measurement of albumin catabolism. When the (
131
1) 
albumin molecule is degraded, the iodine attached to tyrosine 
is released. The behaviour of both the (
131
1) iodide and the 
( 131 1) albumin has been used as an index of albumin catabolism. 
Cohen et al ( 1956) and Campbell et al ( 1956) have shown that 
( 131 1) is liberated only during reactions involving rupture of 
peptide bonds and the former worker e xcluded re-utilization of 
( 131 1) iodide ( in rats whose thyroid glands were blocked by 
prior administration of oral iodine ) , by failing to detect 
plasma protein labelling and by almost completely recovering 
the label in the urine within two days after feeding animals 
( 131 1) proteins. 
After intravenous injection of (
131
1) albumin th e re 
is rapid distribution throughout the intravenous compartment, so 
that the degree of dilution 10 minutes after administration 
provides an index of the plasma volume. Distribution between 
the intra- and extracellular spaces takes place during the 
ensuing two to three days after which the semi-log plot of the 
plasma radio-activity against time is linear. (Fig. 7). 







, r· 1me 
IVA 
Figure 7. Whole-body(WBA), extravascular(EVA),& intravascular 
(IVA), activities after intravenous injection of 
labelled aibumin. TE= Equilibrium time. 
If there are no losses in the urine, gut or other sites the 
albumin catabolic rates may be calculated from this slope 
( Sterling, 1951). However, catabolic rates measured in this 
way are underestimated as there is a bidireactional extra-
intravascular movement of labelled albumin ( Fig. 8 ) . As the 
plasma (
131 I) albumin starts to fall it will receive (
131 I) 
albumin from the extravascular space. For this technique to 
be accurate there must be no net transfer of labelled p rotein 
from the extra- to the intravascular space - so called 
"equilibrium time". It has been proposed ( Campbell et al 
1956 ) that at equilibrium time a tangent to the plasma (
131 1) 
albumin semi-log plot against time ( Fig. 7 ) would provide a 
measure of the albumin catabolic rate as a fraction of the 
plasma protein pool. The Y intercept of this line would 
provide the ratio of intra- to extravascular pool size. 
However, it has been found that the extravascular radioactivity 
required shows a bro a d plateau and the maximum point of the 
curve is difficult to define ( Kelman, 1971). 
Labelled iodide, released by catabolism is distributed 
throughout the body water, e xcreted in the urine, re-utilized 
by the thyroid gland and secreted and re-absorbed by the gut 
( Fig. 8 ) . Thyroid uptake can be blocked by oral administration 
of stable iodine. Gut secretion can be ignored since iodide 
is almost completely re-absorbed. Zizza et al ( 1959), Lewaller 
et al ( 1959) and Mcfarlane ( 1963c ) have established that the 
ma .iority of non-protein-bound radio-activity is free iodide. 
The total iodide released from the labelled albumin, expressed 
as a fraction of the mean albumin-bound activity in the plasma, 











































































































































as a measure of albumin catabolism ( Berson et al, 1953; 
Berson and Yalow, 1954). While accurate estimates of cat
a-
21 • 
bolic rates of plasma proteins depend on steady state con
ditions, 
the method used by the author has been widely accepted as
 
valid even in the unsteady state ( Mathews, 1961; Frank
s, 1963). 
Activity in urine 
= Mass of albumin catabolised. 
Pl asm a a lbumin SA 
Accurate urine collection when using rats as 
experimental models is difficult. In the catabolic studi
es 
c arried out b y the author, therefore, urinary loss of rad
io-
activity was not measured directly, but was derived from 
whol e 
body counts. Experimental work in this laboratory carrie
d out 
by Hoffenberg ( 1968 ) and Kirsch ( 1968) s howed e xcellent 
correlation between this method and direct measurement of
 
urinary (
131 1) loss. Faecal loss does not contribute 
materially to short-term studies of this sort (Hoffenberg
 et 
al, 1966). 
3. Liver Perfusion 
The perfused liver provides inve s tigators with a n 
e x tremely useful tool for examining many facets of its 
behaviour under controlled conditions, not possible in th
e 
inta c t an im al and much more satisfactorily than in tissue
 
cultures. Liver perfusion became established as a labora
tory 
method for research following the work of Miller et al ( 1
951 ) 
and Brauer et al ( 1951). 
Details of technique have varied with investigators; 
however, the principle remains the same. There are two 
different approaches. The first is the 'in situ' technique, 
where the liver remains in the carcass , the whole body of the 
ani~al being placed in the perfusion cabinet. The second 
method commonly used involves removal of the liver from the 
ca r c ass and perfusing it on a dish i n the ca b i net. The former 
te c hnique has several advantag es : it o bvia t es th e necessity 
of handling the liver, the correct po s itioning of the liver is 
ensured and the ischaemic time is reduced by omitting the 
di s section of the liver from the carca s s. 
The technique used in thi s s tudy involv e s c annulation 
of the portal vein, cannulation of the inferior vena cava 
a bove the inflow of the hepatic veins, cannulation of the bile 
du c t and ligation of the inferior vena cava (just above the 
inflow of the renal vessels) and hepatic artery ( Fig. 9). 
The perfusion is carried out in a temperature and 
humidity controlled cabinet. The liver is perfused with a 
medium containing adequate nutrients ( see appendix) and 
having a suitable oxygen carrying capacity, maintained at 
physiological pressure, pH, oxygen and carbon dioxide tension. 
Microscopy has been used to verify cellular integrity. 
This simple experimental model provides the investigator 
with a tool in which the effect s of va rying a vailable specific 
nutrients or hormones, together or separately, can be observed, 
without the interference of the systemic variations that would 
be the consequence of these changes in the intact animal. 
Perfusions were carried out by the author as described by 























































































































M A T E R I A L S A N D M E T H O D S 
MATERIALS AND METHODS 
The principles of methodology have been discussed. 
The detailed methodology is given in the appendix. Essential 
features are summarized. 
Male Wistar rats, weighing between 250-300 g. 
housed in individual cages under controlled conditions of 
temperature, humidity and lighting were permitted water ad 
libitum and unless otherwise stated had free access to a 
balanced diet. 
Partial hepatectomies were performed under diethyl-
ether anaesthesia with the removal of the median and 
left lateral lobes as described by Higgins and Anderson 
( 1931) - see appendix. Sham operations consisted of laparotomy 
and palpation of the liver only. 
Radioactive Materials 
All the radioactive materials used in these 





S d . (14C) o 1um carbonate - specific radioactivity 
58.9 mCi/mM. 
Sodium (
131 1) iodide - specific radioactivity 
40 mCi/mL. 
Sodium C
125 I) iodide - specific radioactivity 
100 mCi/mL. 
23. 
1 • Measurement of plasma albumin levels (in vivo) 
following partial hepatectomy. 
Eighteen rats were divided into three groups: 
control, sham-operated and partially-hepatectomized in such 
a way that each control had a sham-operated and a partially-
hepatectomized partner of similar weight. 
On day zero, partial hepatectomies were performed 
on the six rats in that group. They were weighed post-
operatively and returned to their individual cages where 
they received water ad libitum and in which there was a 
pre-weighed amount of food contained in a vessel designed 
to minimize spillage. The animals had become accustomed 
to feeding from these vessels prior to surgery. 
On day one the sham operations were performed and 
that group of rats weighed post-operatively. The control 
animals were weighed and they and the sham operated animals 
were given exactly that amount of food which their partially-
hepatectomized partners had eaten during the preceding 
24 hours. Each day animals were weighed and each trio 
(partially-hepatectomized, sham operated and control) 
consumed the same weight of food as indicated above. 
In the first experiment the partially-hepatectomized 
animals were exsanguinated on day 3, and the sham operated and 
control rats exsanguinated on day 4. In the second experiment 
the same procedure was adopted, except that the animals were 
exsanguinated on days 10 and 11 respectively. 
Plasma albumin was estimated by the method of 




Measurement of albumin synthesis rates (in vitro) 
following P?rtial hepatectomy _(including effects of 
amino acids and hydrocortison~) 
A perfusion cabinet designed to house isolated liver 
perfusions at constant temperature (37°C) and humidity was built 
in the workshop of the Department of Medicine, University of 
Cape Town. The livers were perfused using the technique 
described by Hems et al (1966). The details of perfusion 
technique and perfusate constituents are given in the appendix. 
Portal pressure was kept constant at 15 cm of water and pH was 
maintained at 7.35 - 7.45 by addition of aliquots of 4.2% 
sodium bicarbonate as indicated by a continuously reading pH 
meter in the reservoir. p0 2 an
d pC0 2 w
ere maintained at 
150 - 175 and 35 - 40 mm.of mercury respectively. 
Production of urea and glucose was determined by measuring their 
levels in the perfusate before and after perfusion on a technicon 
auto-analyser (Technicon Auto Analyzer, Technical Instrument Co. 
Ltd., London, England) with appropriate standards. Livers were 
not considered to be viable in the presence of any of the 
following: i~adequate bile, urea, glucose production or 
perfusate flow rate; liver swelling or visible infarcts. 
The author is aware that albumin synthesis measured 
in liver perfusions does not reflect realistic (in vivo) rates. 
However, since the purpose of the project was not to measure 
absolute albumin synthesis rates but to compare these rates 
under different conditions, the author felt that the technique 
was justified. In retrospect the results obtained from the 




All perfusions were carried out between 10.00 a.m. and 
noon to avoid variations due to circadian rhythms and in groups 
of partially hepatectomized, sham operated and control, each 
group of 3 consuming the same weight of food during the pre-
perfusion period. The perfusions were performed at 6, 12, 18, 
22, 72 hours and 7 days after partial hepatectomy or sham 
operation. Sham operations were not performed in the 72 hour and 
7 day groups. At the end of each perfusion the liver was flushed 
out with cold normal saline excised from the carcass, dried 
between two pieces of gauze and weighed. The liver was then 
0 
placed in a dry oven ( 120 ) and weighed repeatedly until 
no change in weight occurred. The perfusate was spun down 




c) carbonate was added to the reservoir 
after 30 minutes of perfusion by means of a constant infusion 
pump, 250 uCi being infused over a period of 2 hours. 
of perfusate were taken at the start and finish of the 
perfusion. 
Samples 
Albu min synthesis rate was measured by the method of 
McFarlane ( 1963a) and Reeve et al ( 1963). The formula used 
was equation No. 6 ( see Principles of Methodology). The 
specific radioactivity of urea and of albumin was determined from 
the pre- and post-samples. 
of Fernandez et al (1966). 
Albumin was measured by the method 
Urea specific activity was measured on deproteinized 
plasma samples, incubated with urease to produce 
which was then released by the addition of acid. 
The volume of gas produced was measured manometrically on a 
high vacuum gas train, collected in phenylethylanine-
methanol and counted in a PPO-POPOP toluene scintillator in 
a Beckman Automatic Scintillation Spectrometer. Samples 
were counted to an error of less than 3%. The specific 
activity of the guanidine carbon of arginine in albumin 
was obtained by extraction of albumin from the perfusate 
by the acid ethanol method of Korner and Debro (1956). 
0 
After acid hydrolysis at 110 , the sample was passed through 
a column of deacidite FF resin in the bicarbonate form to 
separate arginine which was then incubated with arginase to 
produce urea. The sample was then treated as for urea. Urea 
27. 
was measured by a modification of Nessler's method (Heniyi 1966). 
(a) Effect of supplementary amino acids on albumin 
synthesis rate. 
The effect of amino acids on albumin synthesis was 
examined only in the group 12 hours after partial hepatectomy. 
In addition to the Sodium (
14
c) carbonate, arginine, asparagine, 
isoleucine, leucine, lysine, methionine, phenylalanine, praline, 
threonine, tryptophan and valine were added together to the 
perfusate, before commencing with the perfusion, to a 
concentration of 10 times the normal peripheral blood 
concentration as previously defined (Kirsch et al, 19689). 
Details are given in the appendix. Only L-isomers of amino acids 
(British Drug Houses, Poole, Dorset, U.K.) were added to the 
perfusate. 
( b ) Effect of hydrocortisone on albumin synthesis rate 
after partial hepatectomy. 
The effect of hydrocortisone on albumin synthesis was 
examined only in the group 12 hours after partial hepatectomy. 
In addition to the Sodium (
14
c) carbonate, 30 minutes after 
the start of the perfusion, 2 mg. hydrocortisone (hydrocortisone 
sodium succinate injection of B.P. Glaxo Laboratories Ltd., 
Greenford, England) was added to the reservoir as a bolus 
and 0.949 mg/hr. for 2 hours as a constant infusion. 
3 . Measurement of albumin synthesis rates (in vivo) 
following partial hepatectomy ( including effects of 
supplementary amino acids) 
Each experiment was performed in groups of three: 
partially hepatectomised~ partially hepatectomised to whom 
10 times the normal peripheral blood concentration of amino 
acids ( see ( a) above) was administered orally immediately 
post-operatively (details are given in the appendix); 
sham operated. All animals were "triple-fed" (as in 1 and 2 
above) during the interval between operation and the start of 
the experiment and were given drinking water containing 0.008% 
sodium iodide for at least 24 hours prior to, and throughout, 
the experiment to block thyroidal uptake of radio-iodine 
released by breakdown. 
Sixteen hours after operation a mixture of 14 c-
c arbonate (250 ~Ci) - and 125 1 labelled albumin (10uCi) was 
injected into the tail vein of rats. The simultaneous 
injection of labelled protein enabled plasma volume 
measurements to be made. 
28. 
In addition, by comparing the radio-iodine activity of the 10 
minute sample with one taken at the end of the experiment 6 
hours after injection, the albumin specific activity at 6 
hours could be corrected tot . 
0 
Starting 4 hours after the 
injection of carbonate, the rats were bled at half-hourly 
intervals, 0.1 ml of whole blood being taken from the tail 
into a pipette (thus avoiding extensive blood loss) and 
placed directly into 0.1 ml of 1mgm /m l stable urea and then 
frozen. At 6 hours the animals were exsanguinated by cardiac 
puncture, 0.1 ml of this final sample was placed directly into 
0.1 ml of 1 mgm/ml stable urea and frozen. Plasma was 
separated from the remaining blood and stored frozen until 
assayed. Stable urea and albumin solutions were added to the 
samples to ensure adequate carbon dioxide volumes, appropriate 
corrections being made in the calculations. Serum urea 
estimations on the final sample were done by the Diacetyl 
Monoxime method as it was observed that the iodine in the 
water administered before and during the experiment interfered 
with estimation by Nessler's method which makes use of iodine. 
29. 
Albumin synthesis was measured by the method of McFarlane 
(1963a) and Reeve et al, (1963) as described in 2 above. 
The formula used is equation No. 5 (see Principles of Methodology). 
The specific radioactivity of urea was calculated by extra-
polating the slope of the (
14
c) urea specific radioactivity 
to zero time. The hypothetical specific radioactivity of 
curve 
albumin was obtained by extrapolation to zero time, correcting 
the 6 hour volume by a factor derived from the distribution 
and catabolism of the injected (
125 1) albumin. The urea 
synthesis rate was obtained from the slope of the semi-log 
14 
plot of ( C) urea specific activity versus time. 
4 • Measurement of albumin catabolic rates (in vivo) 
after partial hepatectomy. 
Albumin for this purpose was fractionated from 
rat plasma by the polyethylene glycol method of Polson and Parker 
( 1973). Iodination with ( 131 I) or ( 12 5 I) was achieved by the 
iodine monochloride method of McFarlane (1958) residual 
30. 
free iodine being removed by passage through an anion-exchange resin 
column or by dialysis against dist i lled water. At le as t 99 % 
labelling efficiency was obtained by mean substitution levels 
of 1 atom iodine per molecule albumin. Trichloroacetic acid 
precipitation invariably showed less than 1% free iodine in the 
final sample. Samples were sterili z ed by Seitz filtration with 
the addition of small amounts of carrier albumin or plasma to 
reduce losses and to protect against radiation damage. Final 
preparations were checked by cellulose-acetate electrophoresis 
to ensure absolute chemical purity and homogeneity of the 
labelled product. 
For at least 24 hours prior to the injection and 
throughout the experiment, rats were given drinking water 
containing 0.008% sodium iodide to block thyroidal uptake 
of radio-iodine released by breakdown. 
Eighteen rats were divided into three groups and 
food intake was carefully controlled as described above . in 1 and 2. 
In the first experiment partial hepatectomies were 
performed on day 0. Immediately after operation 0.5 ml of 
iodinated albumin containing 15 - 20 ~Ci of ( 131 I) was 
administered intravenously, following which whole body 
radioactivity was assayed by placing the rats in a well 
ventilated tin, which was counted in a ring of 6 matched 
Geiger-Muller tubes to represent 100% of the administered dose. 
Syringes were weighed before and after administration for 
accurate dose determination. Fifteen minutes after admini-
stration of the (
131
r) 0.8 ml of venous blood was withdrawn 
from the tail for the estimation of total blood volume and 
100% administered dose. On day 1 the sham operations were 
performed and they and the control group were . injected with 
( 131 1 ) and samples taken as above. 0.8 ml venous blood 
for estimat i on of plasma radioact i vity and whol e body c ounts 
were obtained every 24 hours, the partially hepatectomized 
group being exsanguinated on day 10 and the sham operated and 
control groups on day 11. A standard solution was made up on 
day zero c onsisting of a 1 in 1,000 dilution of the 
131 1 dose. 
This was counted daily to enable allowance for natural radio-
act i ve decay to be made. 
Since intravenously administered albumin does not 
reach equilibrium within the extravascular space for approx-
imately 48 hours (Sterling, 1951), the above experiment does 
not provide information regarding the immediate change in 
albumin catabolic rate following partial hepatectomy. A 
second series of experiments was designed to try to get this 
information. 
Here the partially hepatectomized group were 
injected intravenously with 0.5 ml of iodinated albumin 
containing 15 - 20 µCi of (
131 I ) on day D, the sham operated 
animals and controls being injected intravenously with the 
131 
same amounts of ( I) on day 1. Immediately after intra-
venous administration of (
131 1), whole body counts were 
obtained to represent 100% of the administered dose. On day 
I 
31. 
2 partial hepatectomies were performed on the partially 
hepatectomized group and immediately post-operatively they 
were injected intravenously with 0.5 ml of albumin iodinated 
with ( 125 1), 15 - 20 ~Ci. On day 3 the sham operations were 
performed and this group injected intravenously, immediately 
post-operatively, with the same amount of ( 125 1) as were 
the control group. Fifteen minutes after t h e intravenous 
administration of ( 125 1) 0.8 ml of venous blood was with-
drawn for estimation of total blood volume. Separation of 
125 131 . the contributions of ( I) and ( I) was achieved by 
appropriate voltage descrimination. 0.8 ml of venous blood 
and whole body counts were obtained every 12 hours, the 
partially hepatectomized group being exsanguinated on day 5 
and the sham operated and control groups on day 6, that is 
72 hours after operation. A standard solution was made up as 
in the first experiment and counted every 12 hours. The serum 
from all samples was deep frozen until assayed. The plasma 
albumin was determined from the end sample by the method of 
Fernandez et al (1966). 
Catabolic rate was calculated from the ratio of 
daily fall in whole body radioactivity and mean plasma 
specific activity during the corresponding 12 or 24 hours. 
This ratio defined the fraction of plasma albumin catabolized 
per day; the product of this fraction and plasma albumin 
pool provided an absolute catabolic rate ( mg albumin per day). 
32. 
R E S U L T S 
RESULTS 
(1) Plasma albumin levels after partial hepatectomy 
in vivo 
These results and those following sham operation 
together with controls, are shown in Table 1 and Fig. 10. 
On day 3 the difference between the plasma 
albumin levels of the controls and the sham operated 
animals is significant (p < 0.001 ) while there is no 
significant difference between the sham operated and 
partially hepatectomized animals. On day 10 the 
difference between the control and sham operated animals 
is no longer significant, while that between the control 
and partially hepatectomized animals remain so (p< 0.001). 
At this time the difference between the partially hepa-
tectomized and sham operated animals has become significant 
(0.02) p) 0.01). 
( 2 ) Albumin synthesis rates following partial hepatectomy 
33. 
in vitro (including effects of amino acids and hydrocortisone . ) 
These results are shown in Table 2 and Figs. 11 and 12 
and the statistical significance of these results is set out 
in Table 3. It can be seen that the albumin synthesis rate 
falls significantly after the partial hepatectomy both in 
terms of dry liver and animal weight, until 22 hours after 
partial hepatectomy when the albumin synthesis rate has 
recovered in terms of dry liver weight to such an extent 
that it is no longer significantly different from the sham 
operated animal. 
a) Effect of supplementary amino acids on albumin 
~thesis rate. 
The effect of adding 10 times the normal plasma 
concentration of eleven amino acids and the effect of adding 
cortisone to the perfusate is seen in Table 4 and Fig. 13 and 
the statistical significance of these results is set out in 
Table 5. The difference between the albumin synthesis rate of 
34. 
the partially hepate c tomized liver and that after partial 
hepatectomy with added amino acids is significant both in terms of 
dry liver and animal weight. The increase in the albumin synthesis 
rate of the partially hepatectomized liver by adding amino acids 
to the perfusate is such that when considered in terms of dry 
liver weight there is now no significant difference between it 
and the sham operated animal (Table 5). 
b ) Effect of hydrocortisone on albumin synthesis rate 
after partial hepatectomy. 
The increase in aJbumin synthesis rate of the partially 
hepatectomized animal following the addition of cortisone to 
the perfusate is not significant and the albumin synthesis rate 
of the sham operated animals remains signficantly different from 
that of the partially hepatectomized group ( Table 5). 
(3) Albumin synthesis rate following partial hepatec~ 
( in vivo) including effects of supplementary amino 
acids. 
These results are shown in Table 6 and Fig. 14 and 
the statistical significance set out in Table 7. The results 
obtained from the in vivo experiments mirror almost exactly 
those obtained from the in vitro experiments, the only 
difference being that in vivo the partially hepatectomized liver 
is able to synthesize albumin at a rate not significantly 
different from that of the sham operated animals when considered 
35. 
in terms of dry liver weight. Further, these results reveal that 
in vivo the administration of amino acids is able to stimu late 
the partially hepatectomized liver to greater rates of albumin 
synthesis such that this rate now becomes signigicantly higher 
than those of the partially hepatectomized ani mal without 
amino acids, both in terms of the whole animal and dry liver 
weight; 
weight. 
and in the sham operated animal, in terms of dry liver 
In addition, the serum albumin, serum urea, 0-6 
hour albumin guanidine carbon specific radioactivity ratio 
and the fractional synthesis rate of urea were measured to 
ensure that observed changes in albumin synthesis rates we£e 
not in any way artificial (Table 8) . The similarity of 
thP.se results in all three experimental groups confirms the 
validity of the conclusions drawn from the results. 
(4) Albumin catabolic rates following partial 
~tectomy in vivo. 
These results are given in Table 9 and illustrate d 
in Fig. 15 and the statistical significance is seen in 
Table 10. The albumin catabolic rate of the partially 
hepatectomized animals is significantly lower than the 
catabolic rates of the sham operated and control animals, 
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































Fig 11 ALBUMIN SYNTHESIS RATE 
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Fig.12 ALBUMIN SYNTHESIS RATES (IN VITRO) 
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Fig.13 ALBUMIN SYNTHESIS RATES (IN VITRO) 
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ALBUMIN CATABOLIC RATES (IN VIVO) 
in mg/24 hr /3009 rat 
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Calculated from Calculated from 
samples taken samples taken 
every 12 hrs for 72 hrs every 24 hrs for 10 days 

























































































































































































































Experimental work concerning albumin synthesis in 
animals following partial hepatectomy has produced conflicting 
results when these results are expressed as synthesis in terms 
of remaining liver weight. Some workers have reported a fall 
in the albumin synthesis rate (Mutschler and Gordon 1966; 
Murray-Lyon and Muller-Eberhard 1973) others an increase 
(Majumdar et al 1967) while a third group report no change 
in the albumin synthesis rate (Guidotti et al 1959; Braun 
et al 1962; Rosenoer et al 1970; Schreiber et al 1971 ). 
36. 
Despite these differences in synthesis rates per unit 
remnant liver weight, all studies agree that after partial 
hepatectomy there is a fall in plasma albumin concentration. 
This has been confirmed in man (Islami et al 1956; Pack and 
Molander, 1960; McDermott et al, 1963; Monaco et al 1964; 
McDermott and Ottinger 1966; Almersjo and Benmark 1969; 
Aronsen et al, 1969; Dillard, 1969; Flatmark et al 1973). 
The author's results are in agreement with this 
observation. Following partial hepatectomy the plasma albumin levels 
decreased from 2.77 to 2.09 (p < 0.001). Food intake was controlled 
in all groups to exclude changes due to diet. The fall of plasma 
albumin seen in the partially hepatectomized animals after 
three days (2.99 - 2.29 g%) was mirrored to almost the same 
extent by the sham operated animals (2.99 - 2.42 g%). By the 
tenth day, however, the plasma albumin of the partially hepa-
tectomized animals had fallen further to 2.09 g%, while that 
of the sham operated group had been almost completely restored 
(2.58 g%) to the control levels (2.77 g%). 
Since at no time after partial hepatectomy is 
there any significant difference of the albumin synthesis 
and catabolic rates between the control and sham-operated 
animals (see Tables 3 and 9 and Figs. 12 and 15), some other 
mechanism must be instrumental in the fall of plasma albumin. 
Kirsch et al (1968b) demonstrated an immediate fall in the 
albumin synthesis rate following protein deprivation. 
Catabolic rates remained within the normal range until the 
plasma albumin pool diminished after which catabolism 
of albumin rapidly decreased. The author has attributed the 
fall in the plasma albumin of the control •animals (which 
were "triple-fed") during the 10 day post operative period 
(2.99 - 2.77 g%) to protein-calorie deprivation for during 
the entire period their partially hepatectomized partners 
ate considerably less than animals fed ad libitum. 
The initial fall in the plasma albumin of the sham 
operated animals is attributed to the sequestration of albumin 
into non-exchangeable extravascular compartments that has 
been shown to follow surgery (Mourisden and Faber, 1966; 
Mourisden, 1967; Hoye et al, 1972). Mourisden and Faber 
(1966) and Mourisden (1967) have shown an increased elimin-
ation of c
131
r) labelled albumin from plasma of patients under-
going major surgery and have demonstrated a "migration of albumin 
into the oedema of the operative field". Hoye et al (1972) 
investigating fluid volume and albumin synthesis rates in 
patients undergoing major and minor surgery, f~und a reduction 
in plasma volume during major surgery disproportionate to 
the reduction in total red blood cell volume. 
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This was associated with a decrease in both the lymph flow 
in the thoracic duct and the albumin concentration of the 
lymph together with a fall in plasma albumin and the total 
exchangeable albumin pool. 
There is a highly significant increase in protein 
concentration and excretion in the urine in patients 
following surgery (MacBeth and Pope, 1968), this anomaly 
being greater in those patients undergoing major surgery. 
Besides these observations, other less well defined 
factors are involved in circulating albumin loss and 
include: Loss into the abdominal cavity (Jarnum, 1961), 
increased capilllary permeability (Birke et al, 1959/60), 
intravenous infusion (Wasserman and Mayerson, 1952; 
Kaijser and Reiger, 1968) and an increase in fractional 
catabolic rate (Grossman et al, 1960). 
The fall in the plasma albumin in the sham operated 
animals is therefore attributed initially to the sequestration 
of albumin into non-exchangeable extravascular compartments 
together with the other factors discussed and this is 
perpetuated by protein calorie deprivation as happens in 
the control group. 
The evidence that plasma albumin falls following 
surgery not related to the liver, further complicates the 
matter of investigating albumin metabolism following partial 
hepatectomy. By using sham operated animals the author has 
demonstrated the degree to which sequestration of albumin and 
the other mechanisms discussed above which are instrumental 
in the fall of plasma albumin following major surgery, 
contribute to the fall in plasma albumin following partial 
hepatectomy. 
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Following partial hepatectomy the albumin synthesis 
rate falls significantly. In vitro this fall is greatest 
at 12 hours and least at 22 hours after the operation, when 
the recovery of the albumin synthesis rate of the liver is 
such that when the results are expressed in terms of dry 
liver weight, the synthesis rates of the partially 
hepatectomizea and sham operated animals are no longer 
sign i ficantly different. In vivo the albumin synthesis 
rates of the sham operated and partially hepatectomized 
livers ( in terms of dry liver weight) are not significantly 
different 16 hours after operation. However, it must be 
emphasized that only one third of the original hepatic 
mass remains so that despite the return of the albumin 
synthesis rate to control levels in terms of unit 
hepatic mass, the total albumin synthesis is much less 
than it would be if the intact liver was synthesizing 
albumin; this accounts for the fall in plasma albumin. 
One explanation of the apparent earlier return of the 
albumin synthesis rate of the partially hepatectomized 
liver to that of the sham operated animal IN VIVO may 
be that in the intact animals amino acids and hormones are 
mobilized from the extrahepatic stores in order to maintain 
albumin s ynthesis per unit hepatocyte. In addition, it is 
not expected that in the artificial situation of liver 
perfusion the organ will perform as efficiently as it 
does in vivo. 
Other workers (Rosenoer et al, 1970) using isolated 
rat liver perfusions, found that 72 hours after partial 
hepatectomy, the albumin synthesis rates were significantly 
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increased when expressed in terms of both animal weight 
and dry liver weight. In contrast, in the in vitro 
studies reported here the albumin synthesis rate was 
still significantly depressed when compared to control 
animals both in terms of animal weight and dry liver 
weight 72 hours after partial hepatectomy. At no time 
during this period was an elevation of albumin synthesis 
ra te found in the partially hepatectomized animals. 
These results are more in keeping with those obtained 
from the investigations of serum albumin levels and 
albumin catabolic rates in this e xperimental situation. 
It is important to stress that all groups of 
animals were "triple-fed" during the experiments carried 
out to determine albumin synthesis rates, as well as in those 
investigating serum albumin levels and albumin catabolic 
rates after partial hepatectomy. 
Rothschild et al (1966) have postulated an 
extravascular osmotic regulatory system controlling albumin 
synthesis and it is known that albumin is sequestered in 
extravascular compartments post-operatively. The raised 
extravascular osmotic pressure caused by this sequestration 
of albumin may be one mechanism whereby the albumin 
synthesis rate is depressed in the early stages after 
operation. Although the albumin synthesis rate of the 
partially hepatectomized and sham operated animals are 
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no longer significantly different 18 , - 22 hours post operatively 
(when expressed in terms of dry liver weight), this hypothesis 
is not supported by the highly significant differences 
between these two groups at the earlier intervals 
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post-operatively, even when considered in terms of liver weight. 
Because of the integral role of amino acids in liver 
protein synthesis, the investigation of their effect on 
albumin synthesis following partial hepatectomy, was under-
taken. Christensen et al (1948) and Braun et al (1962) 
showed that the levels of amino acids in the liver are 
increased at an early stage after partial hepatectomy and 
it has been demonstrated that amino acids are mobilized 
for plasma protein synthesis in in vivo experiments on 
nephrotic rats . (Drabkin et al, 1962). 
These findings were confirmed more recently by Ferris 
and Clark (1972) who showed a rise in both hepatic and plasma 
free amino acid concentrations during the first four hours 
after partial hepatectomy as compared to sham operated 
animals. Using in vitro techniques Marsh and Drabkin (1958) 
and Peters (1959) were unable to demonstrate an accelerating 
effect of added amino acids on the albumin synthesis rates. 
Clemens (1972) however, has shown an increase in protein 
synthetic activity in cell free systems after exposure to 
high concentrations of amino acids, while Kelman et al 
(1972b) using the isolated perfused rat liver demonstrated 
the ability of certain amino acids, in high concentration, 
to restore the albumin synthesis rates of isolated perfused 
livers from starved rats to normal levels. 
The author has clearly demonstrated that by adaing 
10 times the normal plasma concentration of eleven amino 
acids the increase in the albumin synthesis rate is highly 
significant, both in vivo and in vitro. 
The amino acids were added, in vitro, to the 12 hour post-
partial hepatectomy group since it is at this time that the 
albumin synthesis rate is most depressed and any effect the 
amino acids might have would be more readily appreciable. 
It is possible that if amino acids are added to the group 
22 hours post-partial hepatectomy, the albumin synthesis 
rates may be returned to normal (c ontrol) values. 
These results indicate that amino acid supplementation 
enhances not only the absolute amount of albumin synthesis 
but (in vivo) enables the hepatic remnant to synthesize 
albumin at rates greater than the sham operated animal in 
terms of dry liver weight. 
Braun et al (1962) rave claimed that in the early 
stages of liver regeneration precedence is given to the 
biosynthesis of cellular proteins and that after the 
regenerative process is well advanced, the increased 
construction of plasma albumin is metabolically favoured. 
One hypothetical mechanism whereby amino acids stimulate 
albumin synthesis could be that as a result of the 
redistribution of cellular amino acids following partial 
hepatectomy, the supply of primary substrate for albumin 
synthesis is limiting (Fig. 16). 
Alternatively, if depression of albumin synthesis was 
due to a limited availability of specific tRNA's or amino 
acid tRNA synthetases, this restriction could be partly 
reversed by increasing cellular amino acid concentrations 




















































































































































































































































































































































































































The observations that amino acids stimulate albumin 
synthesis could thus be reconciled with either explanation, 
although the present data are insufficient to indicate 
which mechanism is in fact the predominant one. Either 
hypothesis provides an explanation for both the initial fall 
in the albumin synthesis rate following partial hepatectomy 
and the ability of amino acids to increase it. 
Nolan and Hoagland ( 1971 ) have shown (in vitro) that 
following partial hepatectomy the initial rate of amino 
acid incorporation into protein in regenerating microsomes is 
approximately twice that of normals. In the isolated perfused 
rat liver high concentrations of amino acids are known to 
maintain aggregation of ribosomes, said to be essential for 
normal albumin synthesis (Kelman et al, 1972b). However, 
in livers exposed to ethanol, albumin synthesis is enhanced 
by addition of amino acids while the ribosomes remain in a 
disaggregated state (Rothschild et al 1971). The role of 
ribosomal aggregation therefore remains unclear. 
43. 
While the mechanism remains obscure, it is of clinical 
importance that the administration of amino-acids to patients 
with low serum albumin levels may increase the albumin synthesis . 
rates and so assist in restoring the serum albumin to near 
normal levels. Recent work by Skillman et al (1976), 
demonstrating that intraveous infusion of amino acids in 
patients who had undergone major gastro-intestinal-tract 
surgery significantly increased albumin synthesis rates 
when compared to controls who received 5 per cent glucose, 
suggests that amino acids have a similar effect in man. 
Following on the work by this author, Kirsch et al 
(1976) have demonstrated that keto-analogues of branch-
chained amino-acids (leucine, isoleucine and valine) are 
44. 
able to reverse the reduced synthesis rate observed when 
isolated livers, from well nourished animals were perfused 
with blood from rats deprived of dietary protein for 48 hours. 
Furthermore, these keto-analogues increased albumin synthesis 
per unit dr y live r weight to above normal levels when admini-
stered orally to rats 16 hours after partial hepatectomy. 
This is the first demonstration that synthesis of an 
individual protein may be affected by a non-nitro genous 
nutrient. It remains speculative as to whether the keto-
analogues act directly or exert their effect only after 
transamination to amino acids. 
Keto-analogues of essential amino acids have been 
proposed as a method of treating patients with uraemia, 
portosystemic encephalopathy as well as individuals with 
carbamyl phosphate synthetase deficiency, (Walser et al, 
1973; Maddrey, et al, 1974 and Batshaw et al, 1975). 
The basic treatment of these patients consists of witholding 
nitrogenous compounds which results in reduced albumin synthesis 
(Kirsch et al, 1968a). The finding that keto.-analogues are 
able to increase albumin synthesis rates after partial 
hepatectomy in the same way as amino acids are able to, may 
have clinical implications in that by using keto-analogues in 
patients in whom dietary protein restriction is essential, 
protein synthesis can still be maintained. 
Great interest has been shown in the role of 
insulin and glucagon in the control of liver cell proliferation. 
This has provoked much experimental work in this direction 
and the effect of these hormones on protein synthesis has 
been studied extensively (Tavill et al, 1975; Miller, 1976). 
Physiologically insulin is anabolic; it increases 
protein synthesis partially by increasing the incorporation 
of amino acids into proteins (an action that is independent 
of its effect on glucose metabolism) and partially by the 
protein sparing action of ensuring adequate intracellular 
glucose supplies. Insulin is thus a hormone of energy 
storage: glucagon, on the other hand, is a hormone of 
energy release. In particular, in this context, the latter 
stimulates gluconeogenesis from available amino acids. 
Using isolated rat liver perfusions Haft and Miller 
(1958) and Miller (1961) have confirmed that ins~lin increases 
albumin synthesis and Miller (1960) confirmed that glucagon 
was the hormone of protein catabolism in the liver. Tavill 
et al (1975) using the isolated rat liver perfusion technique 
showed an "anti-anabolic" role for glucagon in albumin 
synthesis which could not be prevented by increased amino 
acid supply or insulin. They further showed that, in contrast, 
the catabolic effects of glucagon were probably confined to 
the intracellular proteins and available amino acids and 
these effects could be inhibited by a relatively low insulin: 
glucagon molar ratio. 
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Miller (1976) claims, however, that the unfavourable effects 
of glucagon on albumin synthesis were reversed by giving 
insulin simultaneously. It is thus clear that a study of 
the effect of these hormones on albumin metabolism in the 
regenerating liver ~ould be a worthwhile line of investigation. 
Another factor of importance in relation to albumin 
synthesis is total hormonal balance. While changes in the 
availability of specific amino acids released from altered 
tissue degradation may also play a role in tissue culture, 
cortisone has been shown to increase albumin synthesis per 
se (Ba ncroft et al, 1969). The author was unable to 
demonstrate any alteration in the albumin synthesis rate 
following the addition of cortisone to the perfusate. 
This is in keeping with the findings of Kelman et al (1973) 
who were able to influence ribosomal profiles by adding 10 
times the normal concentration of amino acid to the system, 
but not by adding the following hormones: hydrocortisone, 
growth hormone, insulin, tri-iodothyronine and glucagon. 
Two sets of experiments were carried out to investigate 
albumin catabolism following partial hepatectomy - a short-term 
experiment to investigate the immediate effect of partial 
hepatectomy on albumin catabolism and a longer term study 
to allow these changes to be observed for 10 days. There 
is excellent correlation between the two experiments, both 
indicating an immediate significant fall in the albumin 
catabolic rate following partial hepatectomy as the system 
endeavours to maintain the plasma albumin pool. This 
finding is in keeping with the findings of Kirsch et al 
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(1968a) who observed that a fall in the albumin catabolic rate 
of malnourished rats occurred following the fall in their 
plasma albumin pools as a result of protein calorie 
deprivation. 
It is thus clear that whatever mechanisms are 
instrumental in the fall of plasma albumin following major 
surgery, in the specific case of partial hepatectomy in 
the rat the most significant factor is a redu c tion in the 
albumin synthesis rate, which can be totally corrected by 
the administration of amino acids or their keto-analogues. 
Despite the early recovery of the hepat i c remnant to synthesize 
albumin the plasma albumin remains low for at least 10 days 
because of the reduction in total hepatic mass and hence 
the total albumin synthesizing machinery. 
47. 
S U M M A R Y 
SUMMARY 
This thesis concerns albumin metabolism following 
partial hepatectomy in the rat. The parameters of albumin 
metabolism that were studied were: 
1. Plasma albumin levels following partial hepatectomy. 
2. The effect of partial hepatectomy on the albumin 
synthesis rate. 
3. The effect of supplementary amino acids on the albumin 
synthesis rate following partial hepatectomy. 
4. The effect of hydrocortisone on the albumin synthesis 
rate following partial hepatectomy. 
5. The effect of partial hepatectomy on the albumin 
catabolic rate. 
The plasma albumin levels were studied in vivo while 
the effect of partial hepatectomy on the albumin synthesis 
rate, effect of supplementary amino acids and of hydrocortisone 
on the albumin synthesis rate following partial hepatectomy 
were all studied both in vivo and in vitro. The effect of 
partial hepatectomy on the albumin catabolic rate was 
studied in vivo. 
A review of liver cell proliferation has been given 
and the introduction deals with the inevitable association 
between studies of albumin metabolism in the partially 
hepatectomized liver and liver cell proliferation. The 
clinical relevance of information concerning both liver 
cell proliferation and albumin metabolism following 
partial hepatectomy is stressed and the available literature 




In the principles of methodology a detailed account of 
the method used to measure albumin synthesis is given and it 
is emphasized that the use of radioactive isotopes in this 
area is vastly superior to other methods previously used 
especially the derivation of albumin synthesis rates from 
catabolic studies of subjects assumed to be in nutritional 
equilibrium, when synthesis was presumed to equal catabolism. 
A brief account is gi ven of the work leading up to the method 
used by the author, described by McFar la ne ( 1963a) and by 
Reeve et al (1963). Likewise a background is given to the 
development of the method used in estimating albumin cata-
bolism which was measured using iodine labelled albumin. 
The results obtained by the author demonstrate a 
significant fall in plasma albumin after partial hepatectomy 
which is not transient as · is the fall in the sham-operated 
animal. The fall in the plasma albumin seen in the "triple-
fed" control animals during the 10 day post-operative period 
is attributed to protein calorie deprivation while the fall 
in the plasma albumin of the sham-operated animals is attributed 
to the sequestration of albumin into non exchangeable extravascular 
compartments together with protein calorie deprivation . 
There is a significant decrease in the albumin synthesis 
rate both in vitro and in vivo in terms of whole animal 
weight while in terms of dry liver weight there is an 
initial fall in the albumin synthesis rate in vitro which 
returns to the rate of the sham-operated animals after 22 hours; 
in vivo no significant fall occurs in terms of dry liver 
weight. It is stressed that despite the return of the albumin 
synthesis rate to control levels in terms of hepatic mass 
the total albumin synthesis is much less than it would be 
if the intact liver was synthesising albumin, thus 
accounting for the fall in plasma a lbu mi n levels. 
The addition of 10 times the normal plasma 
concentration of 11 amino acids is shown to almost double 
these values (in vitro), significantly increasing the 
albumin synthesis rate so that when c onsidered in terms of 
liver weight there is no significant difference between the 
partially hepatectomized and the sham-operated animals. In 
vivo the addition of these amino acids enhances albumin 
synt hesis t o such an extent that t he pa r ti ally hepa t ec tomi z ed 
animal now synthesizes albumin at a rate significantly 
greater than that of the sham-operated animal. 
Hydrocortisone is demonstrated to have no effect 
on albumin synthesis rates either in vivo or in vitro. 
Albumin catabolic rates following partial hepa-
tectomy are shown to fall following the decrease in albumin 
synthesis rates as the system endeavours to ma intain the 
plasma albumin pool. 
Hypothetical mechanisms whereby amino acids may 
stimulate albumin synthesis following partial hepatectomy 
are aluded to in the discussion where the clinical importance 
of the fact that the administration of amino acids to 
patients with low serum albumin levels may increase the 
albumin synthesis rate is stressed. It was this discovery 
by the author which stimulated the research leading to the 
documentation of the important fact th a t ketoanalogues of 
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branch-chained amino acids increase albumin synthesis rates 
(per unit dry liver weight) to above normal levels when 
administered orally to rats after partial hepatectomy. 
The discovery that these non-nitrogenous ketoanalogues, too, 
can increase albumin synthesis in this situation confirms the 
hypothesis that these compounds may be useful in the therapy 
of patients who, for example, are uraemic, have porto-systemic 
encephalopathy or suffer from carbamyl phosphatase deficiency. 
The role of insulin and glucagon in the control of 
liver cell proliferation is discussed and the importance of 
further investigation in this direction is mentioned. 
Possible mechanisms whereby insulin and glucagon may have 
some control of liver cell proliferation is discussed. 
The work described in this thesis, therefore, has 
expanded the existing literature concerning albumin synthesis 
following partial hepatectomy in this way: 
1. ·clarifying the effect of partial hepatectomy 
2. 
3 . 
on albumin synthesis rates (there being considerable 
difference of opinion in the literature hitherto). 
Demonstrating for the first time the beneficial 
effect of certain amino acids on the albumin 
synthesis rates in this situation. 
Elucidating the role of albumin catabolism in the 
fall in serum albumin which occurs following 
partial hepatectomy. 
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A P P E N D I X 
A. LIVER PERFUSION 
( 1) Appara ~us: 
Set up apparatus as in Fig. 18. Care 1s taken to 
ensure that the pressure in the portal vein 1s exactly 
18 cm . perfusate . 
( 2) Perfusate: 
(3) 
Blood was obtained from rats,kept under the same 
conditions as those perfuseq,by ca rdiac puncture 
under diethyl ether anaesthesia . 
1. 56 ml whole blood. 
2. 4 ml heparin ( 1,000 units / ml - heparin injection 
1:3 . P ., Evans Medical Ltd., Speke, Liverpool, 
England) . 
3. 25 ml Plasmalyte B (B axter-Saphar Laboratories Ltd., 
Johannesburg, South Africa) containing g / 100 ml: 
Sodium Chloride 0.6, Potassium Chloride 0.03, 
Magnesium Chloride 0 .0 3 and Sodium Bicarbonate 
0 . 2 3 . 
4 . 2 ml of 4.2 % Sodium Bicarbonate. 
The final haematocrit was 25 %. 
Operative techni~: 
The rat is anaesthetized 1n a plastic bag into which is 




containing 15 - 20% 
of diethyl-ether. When un co~~cious the animal 1s 
placed on the operating table under co ntinuous 
anaesthesia. 
The abdomen is opened through a mid-line incision and 
mid-transverse incisions to left and right of the mid-
line are made, avoiding the larger ves se ls. Bleeding 
is minimized by clampi ng the major vessels of the 










b . Clamp 
c. Canula in portal vein 

















The intenstines are then placed to the animal's left, between 
layers of tissue wetted with warm saline, so that the liver, 
portal vein, right kidney, inferior vena ca va and the bile duct 
become expose d. The thin strands of connective tissue between 
the right lobe of the liver and the vena cava are cut and a loo se 
ligature of silk ( size 3/0) is placed around the cava above 
the right renal vein. 
Next the bile duct is cannulated by a 30 cm. length of 
Portex tubing size PP10 cut at an angle to provide a sharp 
point. The ca nnula is inserted and pushed to the point where 
the duct arises from its branches and sec ur ed with a silk 
ligature. 
Three loose ligatures are passed around the portal vein 
at intervals of 3-4 mm. below the point where the vein divides 
to enter the separate lobes of the liver a nd a fourth ligature 
1s placed aro und the vein at a point distal to the liver. This 
ligature is tied, s hutting off the blood supply from the viscera 
to the portal vei n, the portal vein is then incized with a 
pair of s harp ophthalmic scissors a nd cannulated with a naso-
gastric tube ( French siz e 8, Pha r masea l lncorp. Tao Alta, 
Puerto Ri co) whose tip has bee n drawn out over a gas -fl ame a nd 
fashioned to be easily introdu ce d into the portal vein. This 
naso-gastric tube is attached to the end of a con venti onal 
intravenous givi ng set which is delivering Plasmalyte B 
0 
( see perfusate ) warmed to 37 C. The drip i s a djusted s uc h that 
the fluid is co ntinuously running s lowl y out of the ca nnula 
while it is introduced into the portal vein thus avoiding air 
emboli. Care is taken that at no time is the pressure of the 
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fluid greater than 18 ems. water. The three loose ligatures 
are tied securing the cannula in place. 
The thorax is opened by a transverse incision just 
above and along the line of the diaphragm and by two longit-
udinal incisions towards the head from the two ends of the 
transverse incision. The chest wall is flapped back towards 
the head and a large ( 15 cm) pair of artery forceps is placed 
along the base of the flap and locked in position. The flap 
is then cut off. The vagus and phrenic nerves and oesophagus 
are c ut about 1 cm. above the di ap hr agm to paralyse the 
diaphragm and to eliminate possible vasoconstrictor effects 
of the vagus, and a loose liyature is pla c ed around the 
inferior vena cava close to the heart. 
The cannula that is placed in the inferior vena 
cava is the remainder ot the naso-gastric tube described 
above, whose tip is suitably fashioned. The right atrium 
is incized sufficiently to allow the ca nnula to be introduced. 
It is then passed down the inferior vena cava towards the dia-
phragm as far as it will go and then tied in position. At 
this stage, the loose ligature around the abdominal vena 
cava is tied. 
The preparation is then transferred to the 
perfusion apparatus, ca re being taken not to allow any air 
into the cannula in the portal vein. The effluent from the 
ca nnula in the inferior vena cava is co lle cted and discarded 
until the plasmalyte B has been c leared and perfusate is 
being delivered. The ca nnula is then placed into the 
reservoir. The whole operation takes about 10 mins. and 
the ischaemic time ( the period between tying the distal 
ligature around the portal vein and commencing the flow of 
perfusate through the liver) is 70-90 seconds. 
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An indication of the success of the operation is 
a uniform red colour of the perfused liver, indistinguishable 
from the colour in vivo. An extended interruption of the 
liver circulation may cause an initial patchy perfusion, 
indicated by uneven colouring from which the liver may not 
completely recover. 
At 15 min. intervals 0.3 ml perfusate are withdrawn 
from the reservoir, through the side arm, and the pH, pD 2 
and pC0 2 
measured on an Astrup radiometer. Recordings of 
bile blow rate, perfusate flow rate, liver appearance are 
ma de at the same intervals while ensuring that the ca binet 
temperature and humidity are maintained. A telethermometer 
( Bec kman ) placed between the liver lobes ensures that the 
0 
liver temperature is constant at 37 C and a continuously 
reading pH electrode in the reservoir gives early warning 
of c hange s in the perfusate pH. 
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B. PARTIAL HEPATECTOMY 
The operation is performed under diethyl-ether 
anaesthesia. Through a midline incision reaching 
3 or 4 cm posteriorly from the x iphi s ternum the 
large medi a n lobe of the liver with the left laterial 
lobe, is delivered, secured with stout thread and excised. 
In this way, portions of hepatic tissue ranging from 
68-72% of the total liver are removed, leaving intact 
the right lateral and the caudate lobes . The abdomen 
i s c losed in two layers, using 3 / 0 c hromic catgut for 
the peritoneum and rP.ctus muscle layer and 2/0 silk 
for the skin. 
There is no special post-operative care and complications 
are s urpri s ingly rare, mortality being of the order of 
le ss th a n 0.5%. 
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C. DETERMINATION OF PLASMA ALBUMIN CONCENTRATION 
Reagents: 
(1) 0 . 9% (W/V) NaC 1 . 
( 2 ) HC1 - Ethanol . 
Prepare a mixture of 95% absolute etha nol and 5% 
methanol . To 600 ml of this ethanol-methanol mixture 
add 1.0 ml of concentrated HC1. 
0 
Store at 4 C. 
(3) 0.2M Sodium acetate-ethanol . 
Dissolve 2.7218 mg sodium acetate in 5 . 0 ml methanol . 
0 
Add 95 ml absolute ethanol. Store at 4 C 
(4) 3% ( W/V) sodium hydroxide. 
(5) Biruet reagent . 
Dissolve (i) 17.3 g copper sulphate pentahydrate 
in 100 ml hot di stille d water. 
(ii) 173 g sodium ci tr ate a nd 100 g 
anhydrous sodi um ca rbonate in 000 ml 
distilled water while heating. 
When cool, pour (i i) into ( i) with rapid sti rring 
Dilute to 1 litre with distilled water. 
( 6 ) Protei n Standard . 
30 mg/m l aqueous solution of crystalline hum a n albumin. 
Method : 
( a) To 0 .2 ml of plasma a dd 0.8 ml of 0 . 9% ( W/V) so dium 
c hl o ride. 
( b ) Add 9.0 ml HC1-ethanol. Stopper and mix by inversion. 
0 
( c) Incubate for 30 minutes at 37 C. 
( d ) Centrifuge. 
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Ce) Transfer 5.0 ml of the supernatant to another centrifuge 
tube. 
(f) Add 0.5 ml of 0.2M acetate-ethanol. Stopper and mix by 
inversion. 
(g) Allow to stand at room temperature for 10 minutes. 
( h ) Centrifuge. Pour off supernatant. Invert tubes on 
filter paper to ensure that all supernatant fluid is 
removed. 
(i) Dissolve precipitate in 5.0 ml 3% sodium hydroxide, add 
1.0 ml oiruet reagent, and mix. To one of the triplicated 
samples, omit biuret reagent, add 1.5 ml 3?~ NaOH, in order 
to measure turbidity. 
(j) Read intensity of colour produced after 15 minutes using a 
54 filter on a Klett colorimeter. 
A re age nt blank consists of 5.0 ml 3% sodium hydroxide 
plus 1.0 ml biuret reagent. The known protein standard is 
made by adding 4.9 ml of 3% sodium hydro xi de and 1.0 ml 
biuret reagent to 0.1 ml of 3 g% hu ma n albumin solution. 
5 8. 
D. AMINO ACIDS 
The following quantities of amino acids were added 
to the perfusate in the in vitro experiments or administered 
to the rats in the in vivo experiments. (10 times normal 
peripheral blood concentration, as defined by Kirsch et al 
(1968b). 
Arginine 19.3 mg 
Asparagine 14.4 mg 
Iso-leucine 6.68 mg 
Leucine 1 2. 91 mg 
Lysine 29.21 mg 
Methionine 5. 1 7 mg 
Phenylalanine 7. 7 5 mg 
Praline 31 . 6 3 mg 
Threonine 16. 5 2 mg 
Tryptophan 3.99 mg 
Valine 13.07 mg 
( 1 ) IN VITRO: 
The 11 amino acids, each weighed out sepa rately 
for every experiment and dissolved in 5 ml Plasmalyte B, were 
added to the perfusate which for these experiments was made 
up with 20 instead of 25 ml Plasmalyte B. 
( 2 ) IN VIVO: 
The 11 amino acids, each weighed out separately for 
every experiment, were dissolved in 5 ml distilled water 
and administered to the rat immediately post-operatively 
by means of a naso-gastric tube. 
59. 
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The amino acids were administered again, in the same way, 
one hour before the intravenous injection of 
14
c-carbonate and 
1251 lb . a um.in. 
E. MEASU REMENT OF ALB UMIN SYN THESIS : 
Reagents : 
(1) 10% ( W/ V) a nd 5% (W / V) tr ichloroacetic acid . 
( 2) Absolute ethanol. 
( 3 ) CO2
-free 1N sodium h ydroxide . 
( i) Pr epare CO 2-free
 water by boiling 200 ml 
distil l ed water to half its volume . 
( ii ) To 10 . 0 ml of 1N sodium hydroxide a dd 90 ml 
CO 2-fre
e water. 
Stopper tig htly and prepare a fresh solution 
for each batch of samples pro c essed . 
( 4 ) 4 M citric acid. 
Make 84 g citric acid up to 100 ml volume with 
d is tilled wa t e r . 
( 5 ) Pho s phate buffer ( pH 6.7 ) . 
Di s solve 41 . 7 5 g sodium pyropho s ph a t e a nd 5 . 7 ml 
orthophosphoric acid in 500 ml di s tilled water . 
( 6) Ure a se solution . 
A 1 mg / ml solutio n of urea s e ( Nutritional 
Biochemical Corporation, Cleveland, Ohio, U. S . A. ) 
0 
in phosphate buffer . Store at 4 C a nd r e new monthly . 
( 7 ) 10 % ( W/ V) sodium tung s tate. 
( 8 ) Tungstic acid. 
Make up 10.0 ml 10% ( W/ V) s odium tun gs t a te a nd 3 . 8 ml 
1 N HC1 to 100 ml with distilled wa ter . 
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(9) Citric-tungstic acid soluti6n~ 
A 1 1 mixture of 4 M citric acid and tungstic 
acid. 
(10) 0.66 N sulphuric acid. 
( 11 ) Resins: (Deacidite FF resin is obtained commercially 
in the chloride form - 100-200 mesh; 3.5% cross 
linkage). 
( a) Hydroxide form 
( i) Wash the chloride form with distilled water 
until eluate is clear. 
(ii) Wash with 4 litres of 4 N NaOH. 
( iii) Wash with 4 litres of 2 N NaOH. 
( iv ) Determine if eluate is free of chloride ions by 
testing with silver nitrate at acid pH. 
( v) If necessary repeat washings with 4 N and 2 N 
NaOH until eluate is chloride free. 
( vi) Wash with distilled water to pH 7.0. 
( b ) Carbonate form 
( i) Wash the hydroxide form with two litres of 
0.5 N sodium bicarbonate. 
( ii ) Wash with distilled water to pH 7.0. 
( 12 ) Activated arginase solution. 
Prepare manganese/maleic buffer. 
( i) Dissolve 8.90 g sodium maleate in 200 ml 
distilled water. 
( i i) Br i ng p H to 9.7 - 9.8 wi th 1 N Na OH. 
62. 
(iii) Add 11.5 g manganese sulphate (M nS0 4 . 4H 2 0) 
and make up to 500 ml with distilled water. 
( iv) Bring to pH 7.0 with 1 N HC1. 
Arginase solution is prepared as a 1 mg/ml solution of 
arg1nase ( Nutritional Biochemical Corporation) in manganese/ 
maleic buffer. 
Add required amount of arginase to the appropriate volume of 
buffer, and incubate for 3 hours at 37° C. The solution is 
stored at 4°C and renewed every 2 months. 
( 1 3 ) 
( 1 4 ) 
Phenylethylamine-methanol. 
( i) Re-distill commercially obtained phenylethylamine 
until yellow colour is removed. 
( ii ) 
( iii ) 
Mix with an equal volume of methanol. 
Store in the dark. 
Scintillation mixture . 
Dissolve 7.5 g 2,5-diphenyloxazole ( PPO) and 0.75 g 
1,4-bis-(4-methyl-5-phenyloxazole-2-yl) benzene (POPOP) in 
2,5 litres anhydrous toluene. 
Method 
( a ) Preparation of samples for measurement of alb umin 
guanidine carbon specifi c acti vity. 
( 1 ) Extraction of alb umin from plasma. 
( i ) To 1 ml of plasma add 1 ml of bovine a lbumin 
( ii ) 
( 100 mg / ml British Drug House Chemica ls Limited, 
Poole, England) and add 2 ml of 10 % trichloroacetic 
acid. 
Mix well, centrifuge and discard supernatant. 
63. 
(iii) Wash precipitate with an equal volume of 
cold 5% trichloroacetic acid. Resuspend. 
Centrifuge and discard supernatant. 
( iv) Add 3 volumes of absolute ethanol to precipitate 
Mix thoroughly and centrifuge to remove globulin 
precipitate. 
( v) Dialyse albumin-rich supernatant against 
0 
distilled water overnight at 4 C. 
( vi) Concentrate sample to approximately 2 ml. 
Confirm homogeneity of fraction by cellulose 
acetate electrophor esis . Measure the volume 
and concentration by the biuret method to give the 
total amount of albumin pre se nt. 
( 2 ) Acid hydrolysis of albumin 
( i) Given that 100 ml of 6 N HC1 is added to 250 mg 
protein determine amount of 6 N HC1 required for 
sample (1 vi). 
( ii) Add volumes of water and co ncent rated HC1 to 
samp le so that the final sol uti on is 6 N with 
respect to HC1. 
( ii i ) 
( i V ) 
Transfer to h ydro lysi s tube s and hydrolyse for 
0 
16 hours at 110-115 C. 
Transfer the hydrolysate to a round-bottom flask 
and evaporate to dryness. 
( v ) Wash dried sampl e in flask with 3-5 ml distilled 
water and evaporate to dryness again. 
64. 
( b ) 
( 3) Neutralisation of hydrolysate, and incubation with 
arginase. 
(i) Dissolve amino acid residue in 2-3 ml 
dist i 11 e d water·. 
( ii ) Bring to pH 7.0 by the addition of Deacidite 
FF resin in the carbonate form. 
( ii i ) 
( i V ) 
Pass through a glass column containing 
approximately 5 mm of the carbonate resin. 
Wash the flask with about 10 ml distilled water 
and add washings to the column . 
( v) Collect eluate in a round-bottom flask. 
( a ) add 2 ml activated arginase solution. 
(b) bring to pH 9.0 with 1 N NaOH. 
0 
( c) incubate for 16 hours at 38 C. 
After incubation 
( vi) Bring sample tn pH 2.0 with 4 M citric acid. 
( vii) Evaporate to dryness. 
( viii ) Dissolve this urea in 1 ml of distilled water 
and 0.5 ml phosphate buffer. Bring to pH 7.0 
with CO 2-free 1 N NaOH . 
Sample is now ready for the gas-train. 
Preparation of samples for measurement of urea 
carbon SA 
( i ) In vivo 
Thaw serial samples of blood in stable urea and 
precipitate proteins as in ( ii ) below. 
65. 
( C ) 
In vitro (Perfusion study) 
To 0 . 5 ml plasma from the sample taken at the 
end of the perfusion, add 2.0 ml of stable urea 
(1 mg/ml) - in triplicate . 
(ii) Precipitate proteins by adding 1.0 ml of 10% 
sodium tungstate, and 1.0 ml 0.66 N sulphuric 
acid. 
(iii) Mix well by inversion and leave to stand for 
( i V ) 
5 minutes . Centrifuge. 
Place protein-free supernatant in round-bottom 
flask and evaporate to dryness. 
( v) Redissolve in 1.0 ml distilled water and 0.5 ml 
phosphate buffer. 
( Vi ) Bring to pH 7.0 with CO 2-
free 1 N NaOH. 
Sample is now ready for gas-train. 
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Measurement of CO 2 Specif
ic Activity (Se~ Fig. 19) 
( i) Place sample in centre bulb of reaction vessel (a) 
Place 1 ml urease in one side-arm and 1 ml citric-
( ii ) 
( ii i ) 
( i V ) 
tungstic acid solution in the other side arm . 
Briefly immerse vessel in a solid CO 2-
ethanol 
mixture arid evacuate gases present in solution 
while gently thawing. 
Seal vessel by rlosing tap. 
Tip in urease from side-arm and allow to inc u bate 
for one hour at room temperature . 
Tip acid mixture into reaction vessel and shake 
gently to release CO 2 . 
( v) Place reaction vessel on gas-train and immerse 
in sol id CO 2-
ethanol 


































































( i X ) 
Immerse cold finger (b) in liquid nitrogen and 
allow CO 2 
to pass from reaction vessel to cold 
finger. 
Evacuate any contaminant gases present while the 
CO
2 
sample is trapped under liquid nitrogen in 
the cold finger. 
Close tap above cold finger. Thaw cold finger 
in warm water and then immerse in solid C0 2 -
ethanol, releasing the CO 2 samp
le but trapping 
any contaminant gases. 
( x) Fill cuff ( c) surrounding manometer arm with 
liquid nitrogen and allow CO 2 samp
le to pass 
from cold finger to manometer arm (p reviously 
evacuated) by opening the intervening taps 
an d closing the pump tap. 
(X i ) 
(X ii ) 
( xiii) 
( Xi V ) 
Raise mercury column to trap CO 2 
sample in the 
manometer arm and thaw by adding warm water to 
the cuff. 
Adjust mercury column to the reference mark on 
the modified Macleod c hamber ( d ) to obtain the 
displacement of mercury by CO 2 . 
Note the scale reading indicated by the height 
of the mercury column in the manometer side-arm. 
Evacuate the rest of Lhe gas-train including 
the tube ( e) co ntaining 2 ml of phenylethylamine-
methanol mixture frozen under liquid nitrogen. 
67. 
( d ) 
(xv) 
(xvi) 
Close the pump tap, lower the mercury and 
transfer the CO 2 
to the prepared tube (xiv). 
Remove the tube and after thawing transfer the 
solution to a counting vial containing 8 ·ml of 
the PPO-POPOP scintillation mixture. Count each 
sample for two 20 minute periods in a Beckman 
Liquid Scintillation Counter. 
Calculation of albumin synthesis rate. 
In Vivo: 
+ 
( 1 ) Urea carbon specific activity measurements. 
( i ) Convert volumes of CO into mg C by means of 
2 
( ii ) 
( iii ) 
( i V ) 
a standard graph. 
Calculate SA (Expressed as counts per minute/ 
mg C) for each of urea samples. 
Correct these SA measurements for the stable 
urea added. + 
Plot corrected SA measurement on semilog 
graph paper against time. 
( v ) By the least mean squares method plot the 
best fitting line through these points. 
( Vi ) 
( Vii ) 
Extrapolate the line back to the Y axis 
and determine urea SA at t . 
0 
From the slope determ i ne the fractional SR 
of urect per hour. 
Equal recovery of the stable and labelled urea occurs. 
68. 
(2) Albumin guanidine carbon specific activity measurement. 
(i) Calculate albumin SA as in ( i) and (ii) above. 
(ii) 
( iii ) 
Correct the SA measurement for the added 
* bovine albumin 
Determine albumin SA at t by multipl ying the 
0 
observed SA at t 
0 
by the factor derived from 
the disappearance of the iodinated albumin 
sample over the 6 hour experimental period. 
Th e n: 
Fractional SR of albumin 
= Fractional SR urea x 24 x albumin SA at t 
Urea SA at t 
Absolute SR albumin 
( mg / kg / 24 hours) 
0 
0 
= FSR albumin x intra-vascular albumin pool ( mg ) 
Weight in Kg x 100 
In Vitro ( Perfusion study) 
( 1 ) Urea, carbon radioactivity 
(i ), (i i ) and ( iii ) as before 
( iv ) Calcul a te the urea pool in mg C. 
Ur ea poo l in mg C 
= Perfusate volume ( ml) x final urea c oncentration ( mg %) 
500 
Whe re 12 
60 
= factor for converting mg urea to mg C in urea 
* Equal recovery of the stable and labelled albumin occurs. 
69. 
( 2 ) 
( v ) Calculate the total radioactivity incorporated 
Arginine 
( i ) and 
into urea. 
Total radioactivity incorporated into urea 
(counts/min) 
= urea pool X urea SA 
( mg C) (C / min / mgC) 
carbon radioactivit~ 
(ii) as before. 
( ii i ) Calculate the arginine pooi in mg C. 
Arginine pool 
( in mg guanidine C) 
= ( 100-PCV ) x perfusate volume x perfusate albumin 
concentration x 5.95 x 12 
17,400 X 100 
70. 
Where ( 1 ) ( 100-PCV) x perfusate volume ( ml) = plasma volume (ml) 
100 
( 2) PCV = Packed Cell Volume 
( 3) 5.95 x 12 = factor for converting mg albumin 
to mg guanidine carbon or arginine 
in albumin 
174 X 100 
(4) Albumin concentration expressed in mg/ml. 
( iv ) Calculate the total rad i oa c tivity incorporated 
into arginine. 
Total radioactivity incorporated into arginine 
(counts/min) 
= arginine pool 
(mg/C) 
X arginine SA 
(c/min/mg/C) 
(v) Calculate urea synthesis rate. 
Urea synthesis rate (mg/hr) 




( Vii ) 
Calculate the arginine synthesis rate. 
Arginine synthesis rate (mg/hr) 
= Radioactivity incorporated into arginine x 
urea synthesis rate 
Radioactivity incorporated 
into urea 
Calculate the albumin synthesis rate. 
Albumin synthesis rate ( mg / hr ) 




= amount of arginine in albumin 
( V i i i ) Correct th e albumin synthe s is rate for bod y 
weight. 
Corrected a lbumin synthe s i s rate 
( mg / hr / 30n g) 
= albumin sy nthesis rate x 300 
R 
Wher e R = r a t bod y wei ght. 
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F. DETERMINATION OF UREA CQNCENTRATION (Nessler's method) 
Reagents: 
(1) Urease 1 mg/ml solution. 
( 2) Iodine - stock solution. 2 gm r 2 + 3 gm KI up to 100 ml 
water. Working solution - dilute 1 in 100. 
( 3 ) Nessler's reagent 
( a ) Add 400 ml distilled water to 100 mg Mercuric 
Iodide+ 70 gm KI. 
( b ) Dissolve 150 gm NaOH in 500 ml distilled water. 






Incubate at 37 C 
0.66N H2so4 
Cool thoroughly and add to (a) with constant 
shaking. Make up to one litre with distilled 
water and keep in dark cupboard until reddish 
precipitate settles out. Now ready for use . 
triplicate) 
Blank Standard Samples 
( 50 mgm~~ urea ) 
2.2 ml 2.0 ml 2.0 ml 
0.2 ml 
0.2 ml 0 .2 ml 0.2 ml 
0.2 ml 
for 3/ 4 hour 
0.3 ml 0.3 ml 0.3 ml 
10% sodium tungstate 0.3 mJ. 0 . 3 ml 0 . 3 ml 
Distilled water 5 . 0 ml 5.0 ml 5.0 ml 
72. 
Mix and c entr i fuge at 3000 rpm in ben c h centrifuge for 20 minutes. 
To 5 ml supernatant from each tube add 4.5 ml di s tilled water 
and 0.5 ml working solution of Iodine. Immediately before 
reading add 1 ml Nessler's reagent to each tube. 
Read on Pye Unicam Spectrom~ter at 480 nm. 
G. PREPARATION OF ALBUMIN BY POLYETHYLENE-GLYCOL METHOD 
Reagents: 
(1) Phosphate buffer pH 8.6, 0.067 molar containing disodium 
ethylenediaminetetraacetate (E DTA) 0.01 molar. 
( 2 ) Pulverized Polyethylene Glycol ( PEG). 







( 1 ) 1 part serum plus 2 parts phosphate buffer. 
(2) Add 30% PEG. 
( 3 ) Centrifuge at 10 000 gin 25 rotor in ultracentrifuge 
for 30 minutes. 
(4) Pipette off supernatant fluid. 
( 5) To supernatant fluid add KH
2
Po
4 slowly, while stirring, 
to pH 5 . 6 . 
( 6) Stand on bench for 30 minutes. 
( 7 ) Spin at 10 DOD g for 30 minutes in 25 rotor 1n ultra-
centrifuge . 
( 8 ) Pipette off albumin layer - bottom phase. 
( 9 ) Dilute five times with pH 8.6 buffer. 
( 10) Add 2 volumes c hloro form and shake. 
( 11 ) Spin at 4,000 rpm in Sorvall high-speed centrifuge for 
30 mi nut es . 
( 12) Remove top layer. Dry off chloroform. 
( 13 ) Dialyse against distilled water overnight. 





(1) Approximately 15 mg rat albumin (prepared as in F) contained 
in 0.2 ml volume is used for labelling. 
( 2) Iodine monochloride (stock solution). 
(i) Dissolve 150 mg sodium iodide in 8.0 ml 6N HC1. 
( ii) Dissolve 108 mg sodium iodate monohyd rate in 2.0 ml 
distilled water. 
( iii) Forcibly inject (ii) into ( i) to avoid precipitation 
of iodine. 
(i v) Dilute to 40.0 ml with distilled water and shake with 
5.0 ml carbon tetrachloride. 
The presence of a red discolouration in the organic 
solvent indicates the presence of free iodine. The 
carbon tetrachloride is removed with a pipette, and 
the extraction process is repeated until the carbon 
tetrachloride remains unchanged in c olour . 
( v ) Bubble moist air through IC1 solution for one hour to 
remove any residual carbon tetrachloride. 
( vi) Make up to 45 .0 ml with distilled water. This solution 
0 
is stored at 4 C. 
( vii ) Before use, dilute 1 volume of stock sol ut ion with 9 
volumes of 2M NaC1. 
( 3) Glyci ne buffer (st ock solution) 
( i) Dissolve 7.5 g glycine i n 75.0 ml distilled water. 
( ii) Add 25.0 ml 1N NaC1. 
( 4) Alkaline glycine buffer (pH 9.0 - 9.5) 
Ad d 0.2 ml 1N (W / V) NaOH to 1.8 ml of the stock solution. 
Method 
(a) Prepare alkaline glycine buffer as above. 
(b) Prepare 1.0 ml of a solution of IC1 containing 0.1 ml 
IC1 with 0.9 ml 2M NaC1. 
(c) Place required amount of radioiodine solution in 0.3 ml 
of the IC1 prepared in (b). (Tube A). 
75. 
( d) Adjust pH of albumin solution to 8.5 with alkaline glycine 
buffer (Tube 8). 
( e) Similarly, bring pH of Tube A to 8.5. 
( f) Without delay vigorously and only once inject contents of 
Tube A into Tube B. 
(g) Remove the free iodine by dialysis against distilled water. 
( h) Check the free radioiodine content on an aliquot of the 
final preparation by trichloroacetic acid precipitation to 
ensure less than 1.0%. 
(i) Check that the label is confined only to the albumin 
fraction by cellulose acetate electrophoresis. 
(j) Sterilize by Seitz filtration. 
76. 
I. DETERMINATION OF UREA CONCENTRATION ( Diacetyl Monoxime Method.) 
Reagents: 
( 1) Trichloracetic acid (TCA) - 20% 




( 3) Ferric alum acid Reagent: 








Add distilled water 
Cool, add 
Orthophosphoric acid 
( co nce ntration 85%) 
Mix, add sulphuric acid 
( co ncentrated ) 









In ce ntrifuge tubes prepare protein filtrates : 
( 1 ) Blank Test 
Distil led water 1. 0 ml 0 . 8 ml 
Serum 0 .2 ml 
Standard ure a 
Sta nd ard 
0 . 8 ml 
so lution 0 . 2 ml 
2 0 ?~ TC A 1. 0 ml 1 . 0 ml 
Whirlimix: cen trifuge for 10 minutes at 3,000 rpm. 
s upern ata nt fluid through cot ton-wool pledgets . 
1 . 0 ml 
Filter 
( 2 ) In quick fit tubes: 
Prepared filtrates 
Diacetyl monoxime 
Shake a ll tubes thoroughly. 
Blank 
0.5 ml 






4 . 0 ml 
Add 4 . 0 ml ferric a lum-acid 
reagent to each tube, one at a time, s hake a nd stoppe r and 
p la ce in a boiling water bath at one minute intervals. 
Boil for a fixed period ( 10-15 minutes) and remove in 
s uccession at one minute interval s . Cool in a beaker of 
tap water . After 5 minutes read tubes in s uccessio n of 
o ne minute intervals on Pye Unicam Spectrometer at 470 nm. 
77 . 
J. 
( 1 ) 
MEASUREMENT OF ALBUMIN CATABOLISM 
Assay of samples: 
( i) Deep frozen serial serum samples thawed. 
(ii) 10A of (i) diluted in 3 ml distilled water. 
( iii) Radioactivity assayed in a Packard Autogamma 
Scintillation Spectrometer ( Model 578). 
( 2) Plasma albumin concentration of the final sample was 
determined by the Fernandez method ( see Appendix C p. 57 ) 
( 3) Calculation of Results 
( i) Take immediate post-injection whole-body counts and 
those of the 15 minute plasma sample to represent 
100% of the administered dose. After correction for 
appropriate standards, plot successive daily whole-
body and plasma counts as a percentage of the dose on 
semilog graph paper. 
( ii) Derive best-fitting curves, using least mean squares 
method. 
(ii i) From the graphs, calculate daily urinary loss 
(equivalent to fall in whole-body activity) and mid-
point of plasma activity for the corresponding 24-hour 
period . 
(i v ) Determine daily fractional catabolic rate ( FCR) 
from 
Urinary excretion in 24-hours 
X 100 ~~ 
Mean plasma activity 
(v) Calculate absolute values for catabolic rates from 
fractional rates and plasma albumin pools. 
Albumin catabolic rate (mg/24 hr) 
= FCR x plasma albumin pool. 
7 8. 
( vi ) Correct the albumin catabo lic rate for body weight 
Corrected albumin synthe sjs r a te ( mg / 24 hr / 300g ) 
= albumin catabolic rate x 300 
R 
Where R = rat body weight. 
79. 
K. STATISTICAL METHODS 
( 1 ) Mean X = n 
Standard deviation of the mean. s = 
- 2 E(x - x) 
n - 1 
( 2 ) Student's t-test~ 
t = 
1 
+ 2 degrees of freedom 
( 3) Linear regression analysis ( Method of Least Mean Squares) 
The least square line approximating the set of points 
( x , y ), is given by the 
n n 
equation y = mx + c where 
m = NExy 
NEx 2 
( [ X ) ( [ y ) and c = ( Ey) (r x
2 ) ( Ex) ( Exy) 
NEx
2 - (E x) 2 
( 4 ) Wilcoxon test for two s amples: 
Given two samples 1 and 2 with values x 1 
and x 2 
with 
The values are ranked as a whole . 
sum of the rank numbers for sample 1 = T 1 . 
those for sample 2 = T2 . 
Similarly 
The 
Significance limits for T1 
are given in Do c ument a Geigy 
Scientific Tables P. 124, ( Edited by Konrad Diem, 
published by J.R. Geigy, S.A ., Basle, Switzeriand. Sixth 
edition ) which list probability 
T,e < T < T ~ l - 2a. 
r 
If T1 attains the significance levels or exceeds them in 
the outward direction from its expected value, then this 
may be regarded as evidence that: 
80. 
if T1 
< T ( ~ Ct ) < µ2 = e 
> µ2 if T1 > T ( ~ Ct ) = r 
R E F E R E N C E S 
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